U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07275307) titled 'Impact of Prontosan Wound Gel X on Surgical Site Infections in Cardiac Surgery' on Nov. 18.
Brief Summary: This study aims to evaluate the effects of Prontosan(R) Wound Gel X on the incidence of superficial surgical site infections (SSI) in adult patients undergoing elective cardiac surgery with median sternotomy. The primary objective is to assess how the intraoperative application of the gel impacts the occurrence of SSIs, defined according to CDC/NHSN criteria. Secondary objectives include evaluating the length of hospital stay, the incidence of unplanned re-operations, and identifying any latent clinical subgroups through cluste...